Company Directory / Biotechnology

Insmed logo

Public · NASDAQ:INSMFor profitBiotechnologyBridgewater Township, New Jersey, United States

Insmed

Insmed is a biopharmaceutical company creating medicine for rare diseases.

Founded
1988
38 years ago
Staff
501-1000
1,411 on LinkedIn
Followers
51k
on LinkedIn
Funding
$3.8B
as listed, USD

Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. We are dedicated to making a meaningful impact in patients’ lives as well as the communities where we live and work. Our team is guided by our core values of collaboration, accountability, passion, respect, and integrity. Insmed is headquartered in Bridgewater, NJ, and has offices and research locations throughout the United States, Europe, and… Read all

Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. We are dedicated to making a meaningful impact in patients’ lives as well as the communities where we live and work. Our team is guided by our core values of collaboration, accountability, passion, respect, and integrity. Insmed is headquartered in Bridgewater, NJ, and has offices and research locations throughout the United States, Europe, and Japan. We are proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending four consecutive years as the No. 1 Science Top Employer. Join the Insmed team to accelerate your career and help make every moment and every patient count. Community guidelines: http://bit.ly/3DbEjVG

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

501-1000 people: larger than 95% of companies with a size listed. 1,411 people list it on LinkedIn.

Age

198819002026

38 years old.

Reach

Website ranked #505,411 in the world for traffic, about 67k visits a month. 50,890 followers on LinkedIn.

What it does

BiotechnologyMedicalPharmaceuticalBiotechnologyOrphan Disease StatePharmaceuticalsChronic Lung InfectionsPulmonary

Funding, as listed

$3.8B raised in total

  • Rounds15
  • LatestPost ipo equity, May 2024
  • Latest amountUSD 750,000,000
  • Investors4, 1 leading

What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.

FoundersJoseph Larner
Acquisitions made3

Every detail we hold

Everything the source datasets list about Insmed, field by field. Contact details are held but never shown.

The company

Name
Insmed
Type
For profit
Status
Public · NASDAQ:INSM
Founded
1988
Founders
Joseph Larner
Industry
Biotechnology
Categories
Biotechnology, Medical, Pharmaceutical
Specialities
Biotechnology, Orphan Disease State, Pharmaceuticals, Chronic Lung Infections, Pulmonary

Where

City
Bridgewater Township
Region
New Jersey
Country
United States
Markets
East Coast, Northeastern US

Size and reach

Staff band
501-1000
People on LinkedIn
1,411
LinkedIn followers
50,890
Web traffic rank
#505,411
Monthly web visits
67,332

Funding, as listed

Total
$3,811,200,000 USD
Rounds
15
Latest round
Post ipo equity
Latest round date
May 2024
Latest amount
750,000,000 USD
Investors
4
Lead investors
1
Stock listing
NASDAQ:INSM
Listing status
public

Corporate family

Acquisitions made
3

About this record

Sources
Crunchbase, LinkedIn
Last imported
Sept 2026

Growth, as the source summarises it

Insmed's first quarter 2024 earnings report showed that while the company's EPS beat expectations, its revenues lagged behind. Additionally, the full year 2023 earnings report indicated that Insmed's EPS missed expectations.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Biotechnology in United States.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.